Reports
Reports
Sale
The global smart inhalers market size attained a value of USD 0.78 billion in 2023, driven by the growing geriatric population worldwide, increasing preference towards smart and effective inhalers. The market is forecasted to grow at a CAGR of 17.1% during the forecast period of 2024-2032 to achieve a value of USD 3.25 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Smart inhalers are referred to as the devices that enable the delivery of a variety of medication via inhalation. They are termed as smart due to sensors that are attached to the inhalers monitoring the correct dose per intake as well as the technique used while inhaling the medication.
The smart inhalers market is segmented based on products, indications, and distribution channels.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of products, the smart inhalers market is divided into:
Based on indication, the smart inhalers market is segmented into:
On the basis of distribution channels, the smart inhalers market is divided into:
The EMR report looks into the regional smart inhalers markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global smart inhalers market is driven by the smart and effective manner to inhale the medicine, as compared to the usual inhalers. Recent developments in the manufacturing of smart inhalers, as well as devices having built-in smart inhalers, are expected to aid the smart inhalers market growth. The rise in the prevalence of people who have asthma and chronic obstructive pulmonary diseases is expected to enhance the market growth.
The report presents a detailed analysis of the following key players in the global smart inhalers market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Smart Inhalers Market Overview
3.1 Global Smart Inhalers Market Historical Value (2017-2023)
3.2 Global Smart Inhalers Market Forecast Value (2024-2032)
4 Global Smart Inhalers Market Landscape
4.1 Global Smart Inhalers Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Smart Inhalers Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Indication Type
4.2.3 Analysis by End User
5 Global Smart Inhalers Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Smart Inhalers Market Segmentation
6.1 Global Smart Inhalers Market by Product Type
6.1.1 Market Overview
6.1.2 Dry Powder Inhaler (DPI)
6.1.3 Metered Dose Inhalers (MDIs)
6.2 Global Smart Inhalers Market by Application
6.2.1 Market Overview
6.2.2 Asthma
6.2.3 COPD
6.2.4 Others
6.3 Global Smart Inhalers Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Home Settings
6.3.5 Others
6.4 Global Smart Inhalers Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Hospital Pharmacies
6.4.3 Retail Pharmacies
6.4.4 Online Pharmacies
6.5 Global Smart Inhalers Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Smart Inhalers Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Smart Inhalers Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Smart Inhalers Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Smart Inhalers Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Smart Inhalers Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Adherium Limited
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 AstraZeneca PLC
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boehringer Ingelheim International GmbH
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cohero Health, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 GlaxoSmithKline plc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Teva Pharmaceutical Industries Limited
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Vectura Group plc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
18 Global Smart Inhalers Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global market for smart inhalers reached a value of USD 0.78 billion in 2023.
The market is projected to expand at a CAGR of 17.1% from 2024 to 2032, growing to USD 3.25 billion by 2032.
The industry is driven by the growing geriatric population worldwide, increasing preference towards smart and effective inhalers, the growing investments in the medical sector, and the growing innovations in the manufacturing of smart inhalers.
The key trend propelling the industry growth include the growing incidences of asthma and chronic obstructive pulmonary disease (COPD) worldwide.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The significant products include inhalers and nebulisers.
The major segments based on indication include asthma and COPD.
The significant distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
The major players in the industry are Adherium Limited, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cohero Health, Inc., Teva Pharmaceutical Industries Limited, GlaxoSmithKline plc, Vectura Group plc, and others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.